Ovarian clear cell carcinoma with papillary features: A potential mimic of serous tumor of low malignant potential

American Journal of Surgical Pathology

Volumn 32, Issue 2, 2008, Pages 269-274

  Sangoi, Ankur R ^a   Soslow, Robert A ^c   Teng, Nelson N ^b   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Borderline tumor; Clear cell carcinoma; ER; Frozen section; Low malignant potential; Ovary; Papillary; Serous; WT1

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HUMAN; INFERTILITY; MICROSCOPY; MITOSIS INDEX; OVARY CARCINOMA;

ADENOCARCINOMA, CLEAR CELL; ADENOCARCINOMA, PAPILLARY; ADULT; AGED; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIOSIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 38649110470     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31814fa9b0     Document Type: Article

References (28)

1. Boger-Megiddo I, Weiss NS. Histologic subtypes and laterality of primary epithelial ovarian tumors. Gynecol Oncol. 2005;97:80-83.
2. DeSanto DA, Bullock WK, Moore FJ. Ovarian cystomas. Arch Surg. 1959;78:98-107.
3. Esheba GE, Pate LL, Longacre TA. Glypican-3 distinguishes yolk sac tumor from ovarian clear cell carcinoma. Am J Surg Pathol. In press.
4. Gilks CB, Vanderhyden BC, Zhu S, et al. Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling. Gynecol Oncol. 2005;96:684-694.
5. Kennedy AW, Biscotti CV, Hart WR, et al. Ovarian clear cell adenocarcinoma. Gynecol Oncol. 1989;32:342-349.
6. Klemi PJ, Meurman L, Gronroos M, et al. Clear cell (mesonephroid) tumors of the ovary with characteristics resembling endodermal sinus tumor. Int J Gynecol Pathol. 1982;1:95-100.
7. Longacre TA, Teng NNH, Hendrickson MR. The gynecologic frozen section. In: Ranchod M, ed. Pathology: State of the Art Reviews. Philadelphia, PA: Hanley and Belfus, Inc; 1996:427-492.
8. Mikami Y, Hata S, Melamed J, et al. Basement membrane material in ovarian clear cell carcinoma: correlation with growth pattern and nuclear grade. Int J Gynecol Pathol. 1999;18:52-57.
9. Nishimura S, Tsuda H, Ito K, et al. Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs. Hum Pathol. 2007;38:134-139.
10. Novak ER, Woodruff JD. Mesonephroma of the ovary; thirty-five cases from the Ovarian Tumor Registry of the American Gynecological Society. Am J Obstet Gynecol. 1959;77:632-644.
11. Parker TM, Dockerty MB, Randall LM. Mesonephric clear cell carcinoma of the ovary: a clinical and pathologic study. Am J Obstet Gynecol. 1960;80:417-425.
12. Peham H. Aus accessorischen nebennieren-anlagenentstandene. Ovarial tumoren. Monatsschr F Geburtsh U Gynak. 1899;10:685-694.
13. Ramalingam P, Malpica A, Silva EG, et al. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004;28:1499-1505.
14. Saphir O, Lackner JE. Adenocarcinoma with clear cells (hypernephroid) of the ovary. Surg Gynecol Obstet. 1944;79:539-543.
15. Schiller W. Mesonephroma ovarii. Amer J Cancer. 1939;35:1-21.
16. Scully RE, Barlow JF. "Mesonephroma" of ovary. Tumor of Mullerian nature related to the endometrioid carcinoma. Cancer. 1967;20:1405-1417.
17. Scully RE, Young RH, Clement PB. Atlas of Tumor Pathology. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Washington, DC: Armed Forces Institute of Pathology; 1998:141-151.
18. Scully RE, Clement PB, Young RH. Ovarian surface epithelialstromal tumors. In: Mills SE, ed. Sternberg's Diagnostic Surgical Pathology. New York, NY: Lippincott Williams and Wilkins; 2004:2543-2578.
19. Seidman JD, Russell P, Kurman RJ. Surface epithelial-stromal tumors of the ovary. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag; 2002:791-904.
20. Serov SF, Scully RE, Sobin LH. Histologic Typing of Ovarian Tumours International Histological Classification of Tumours. Geneva: WHO; 1973:37-42.
21. Tan DS, Kaye S. Ovarian clear cell adenocarcinoma: a continuing enigma. J Clin Pathol. 2007;60:355-360.
22. Tavassoli FA, Devillee P. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
23. Teilum G. Histogenesis and classification of mesonephric tumors of the female and male genital system and relationship to benign so-called adenomatoid tumors (mesotheliomas); a comparative histological study. Acta Pathol Microbiol Scand. 1954;34:431-481.
24. Tsuda H, Ito YM, Ohashi Y, et al. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinomas by cDNA microarray analyses. Clin Cancer Res. 2005;11:6880-6888.
25. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18(suppl 2):S61-S79.
26. Vang R, Whitaker BP, Farhood AI, et al. Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract. Int J Gynecol Pathol. 2001;20:252-259.
27. Wick MR, Swanson PE, Manivel JC. Placental-like alkaline phosphatase reactivity in human tumors: an immunohistochemical study of 520 cases. Hum Pathol. 1987;18:946-954.
28. Zirker TA, Silva EG, Morris M, et al. Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1. Am J Clin Pathol. 1989;91:511-514.